Form 4 for NTRA Natera, Inc.
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0001415889-25-020278 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-24 | 2025-07-22+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $139.94 | -2,170 | 70.5K | -3% | -$303.7K |
| D | 2025-07-24 | 2025-07-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 71.7K | +2% | — |
| D | 2025-07-24 | 2025-07-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | $0.00 | -1,250 | 1,250 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-24 | S | D | 458 | $139.20 | 70,791 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.62 to $139.59 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-07-24 | S | D | 297 | $139.95 | 70,494 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. (F5) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.71 to $140.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-07-23 | S | D | 495 | $141.28 | 71,249 | D | — | — | (F3) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021. |
| 4 | Common | Common Stock | 2025-07-22 | M | A | 1,250 | — | 71,744 | D | — | — | (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 5 | Common | Common Stock | 2025-07-22 | S | D | 920 | $139.58 | 70,494 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024. |
| 6 | Derivative | Restricted Stock Unit | 2025-07-22 | M | D | 1,250 | $0.00 | 1,250 | D | — · — to — | 1,250 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F6) The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. |